[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337296-105":59,"doc-detail-337296-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","bioinformatics-examination-of-glioblastoma-identifies-a-potential-panel-of-therapeutic-biomarkers","Bioinformatics Examination of Glioblastoma Identifies a Potential Panel of Therapeutic Biomarkers","","Glioblastoma (GBM) is a highly aggressive brain cancer with poor survival outcomes, making molecular investigation essential for identifying actionable biomarkers. Using bioinformatics, the study compares gene expression between normal brain endothelial cells and glioblastoma tumor cells, applying R Studio and Cytoscape with relevant plugins. Differentially expressed genes form a network implicating TP53, EGFR, FN1, JUN, and CDC42 in key biological processes. The dysregulation of this gene panel may destabilize protein-protein interaction networks, supporting their potential as validated drug targets.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bioinformatics-examination-of-glioblastoma-identifies-a-potential-panel-of-therapeutic-biomarkers/337296/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bioinformatics-examination-of-glioblastoma-identifies-a-potential-panel-of-therapeutic-biomarkers/337296.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of this bioinformatics study on glioblastoma?","Question",{"text":113,"@type":114},"To identify potential therapeutic biomarker candidates by analyzing gene expression differences between normal brain endothelial cells and glioblastoma tumor cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which tools and approach are used for the gene expression and network analyses?",{"text":118,"@type":114},"The study uses R Studio and Cytoscape with its plugins to evaluate gene expression profiles and build protein-protein interaction-related insights.",{"name":120,"@type":111,"acceptedAnswer":121},"What key genes are highlighted as candidates in the resulting DEG network?",{"text":122,"@type":114},"The network highlights TP53, EGFR, FN1, JUN, and CDC42 and links them to relevant biological processes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337296,1790100465,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","RESEARCH ARTICLE  \nEditorial Process: Submission:06/28/2024 Acceptance:11/09/2024  \nBioinformatics Examination of Glioblastoma Identifies a Potential Panel of Therapeutic Biomarkers  \nFatemeh Bandarian1, Farideh Razi2, Zahra Razzaghi3, Mohammad Rostami Nejad4, BabakArjmand5,6, Alireza Ahmadzadeh7,8 *  \nAbstract  \nObjective: Glioblastoma, previously recognized as glioblastoma multiform (GBM), is the most aggressive and most common type of cancer that originates in the brain and has a very poor prognosis for survival. Glioblastoma, as one of the lethal cancers ofthe brain, is important to be studied in terms of molecular exploration. Methods: Bioinformatics approaches could be a promising complementary study for identifying more robust biomarkers. This study evaluates the gene expression profile of normal brain endothelial cells versus glioblastoma tumor cells with positive CD3 in more depth by applying R Studio and Cytoscape and its plug-ins. Results: A network of differentially expressed genes (DEGs) introduced promising candidates comprised of TP53, EGFR, FN1, JUN, and CDC42 and their related biological processes. Comprised of differentially expressed genes, this panel’s dysregulation could significantly affect the stability of the protein-protein interaction (PPI) network. Moreover, previous studies have validated these genes’relevance to this cancer type. Conclusion: In conclusion, the molecular profile of glioblastoma aids in drug targeting following thorough validation assessments. Five key genes and their related biological processes are possible drug targets to control glioblastoma.  \nKeywords: Glioblastoma (GBM)-Endothelial cells-Gene expression-Biomarker panel  \nAsian Pac J Cancer Prev, 25 (11), 4035-4041  \nIntroduction  \nGlioblastoma is the most common heterogenous type of brain cancer, knowing as the malignant tumor of glioma [1] . The likelihood of developing this tumor varies with sex, being more prevalent in males. In addition, the risk of acquiring this tumor increases with age [2] . Taking immediate action to address the issue is crucial due to its lethal nature and the lack of effective treatment options. The treatment choices are surgical approaches, radiation therapy, and alkylating chemotherapy. This deadly cancer leads to fatalities within a year of diagnosis [3] . Molecular analysis could be helpful in terms of identifying prominent biomarkers of the underlying disease mechanism. Moreover, various molecular approaches, including genetic, genomic, and epigenetic factors, suggest the presence of heterogeneity  \nin Glioblastoma. This necessitates the development of targeted therapies tailored to the specific subtypes of individuals rather than a one-size-fits-all approach [4] . However, the complexity of Glioblastoma made it challenging for drug targeting design. The grim prognosis associated with this cancer makes it a prominent research focus, particularly in the realm of biomarker discovery for early detection, prognosis assessment, follow-up care, targeted therapies, and treatment strategies, as previously mentioned [5, 6]. Currently, many studies are focusing on targeting biomarkers of Glioblastoma with different drugtargeting attempts. On of these is RNA-based treatment, which targets genes and ncRNAs (non-coding RNAs) . This regulator has also been reported to treat other cancers [7]. Our study utilized a prior investigation, in which oneof their key findings was the identification of integrin α3β1 as a potential target involved in the formation of  \n1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. 2Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. 3Laser application in medical sciences research center, Shahid Beheshti University of medical sciences, Tehran, Iran. 4Celiac Disease and Gluten Related Disorders ","cbCaiqpzQKGOfIrR","https://ap.wps.com/l/cbCaiqpzQKGOfIrR","pdf",1023981,"English","# Abstract\n# Introduction\n# Materials and Methods","[{\"question\":\"What is the main goal of this bioinformatics study on glioblastoma?\",\"answer\":\"To identify potential therapeutic biomarker candidates by analyzing gene expression differences between normal brain endothelial cells and glioblastoma tumor cells.\"},{\"question\":\"Which tools and approach are used for the gene expression and network analyses?\",\"answer\":\"The study uses R Studio and Cytoscape with its plugins to evaluate gene expression profiles and build protein-protein interaction-related insights.\"},{\"question\":\"What key genes are highlighted as candidates in the resulting DEG network?\",\"answer\":\"The network highlights TP53, EGFR, FN1, JUN, and CDC42 and links them to relevant biological processes.\"}]","Bioinformatics Examination of Glioblastoma Identifies a Potential Panel of Therapeutic Biomarkers | PDF",1790018516,18,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79076ec1ebd2a61ede09584bdd2376dd.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5c00d5e67fd55384b6c2630fed3e827.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ef852b808460283b9bf55e88e0eb4c7.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d756c6fa1461a1279255d51a7dae1cb.webp",980,1385]